Case scenario

Suzette, 28 years old, comes into your pharmacy to access emergency contraception following unprotected intercourse. She was provided with ulipristal last week and has just come from an appointment with her GP. She has not been using any other reliable contraceptive so far, as some of her friends warned her that combined oral contraceptives can contribute to DVTs and she regularly commutes overseas for work. Suzette has been prescribed drospirenone and has been advised to start this for contraception during her next cycle. She would prefer to start this immediately, even though she is on day 20 of her usual 29-day cycle. You recall the interaction between ulipristal and progestogens; however, as it has been more than 5 days since treatment, Suzette can safely start t
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.

Team PSA 2026: Caroline Diamantis FPS, Prof Mark Naunton MPS and Bridget Totterman MPS[/caption]
A/Prof Fei Sim and Prof Mark Naunton[/caption]

Clinical features
Warm compresses are the cornerstone of treatment, helping to soften the lesion, bring pus to the surface and encourage spontaneous drainage. A clean face cloth soaked in warm (not hot) water should be applied to the closed eyelid for 2–5 minutes, twice daily during the active phase. Once the stye begins to drain, any discharge should be gently wiped away using a clean, warm washcloth. After resolution, continuing warm compresses once daily may help prevent recurrence.2 








